- Patient Services
- Get Involved
The Section of Family Planning and Contraceptive Research at the University of Chicago is committed to helping women and girls reach their full potential by bringing a life-course perspective to reproductive health.
see more >
We conduct clinical and social science research to improve the reproductive health of women and adolescents. Our current clinical trial is an investigational study of estrogen-free birth control and we are looking for volunteers. see more >
The Section is proud to provide comprehensive family planning services through our clinics. see more >
Through our policy program, we advocate for policies that reduce disparities and improve the health of families by guiding research priorities and making research findings accessible. see more >
Through our education program, we help individuals and communities achieve sexual and reproductive health. see more >
Job Opportunity: We are looking for a Research Specialist 1 to provide technical and administrative support across the Section and Ci3. For more information and a complete job description, click here (Requisition #095844).
The Section and Ci3 have developed an online toolkit to optimize the delivery of IUD Care. The website provides a set of tools that clinical staff, healthcare providers, and administrators can use to identify and address system-level barriers to uptake of the IUD by clinic patients. Click here to view the toolkit, our study, and guidelines for future provider implementation.
Andrea Friedman of the National Partnership of Women and Families joined us as a part-time consultant.
Doula support during first trimester surgical abortion
Section faculty Dr. Julie Chor published new research on expanding the role of doulas into abortion care. Although this study found no measurable effect on pain or satisfaction, women overwhelmingly recommended doula support for routine care.
Impact of a revised appointment scheduling script on IUD service delivery in three Title X family planning clinics
Research conducted by Dr. Melissa Gilliam and staff shows that a simple IUD appointment scheduling script with clear communication improves LARC uptake.
Development and Testing of an iOS Waiting Room "App" for Contraceptive Counseling in a Title X Family Planning Clinic
A new publication by Section chief Dr. Melissa Gilliam and staff in the American Journal of Obstetrics and Gynecology discusses a quality improvement study that evaluated IUD service delivery.
Contraception for Adolescent and Young Adult Women
Now more than ever, youth need to learn about and use contraception consistently and effectively, which requires best contraceptive counseling and provision practices. Section chief Dr. Melissa Gilliam and Section faculty Dr. Amy Whitaker have co-edited a new, valuable resource for gynecologists and primary care practitioners that provides evidence-based and up-to-date information as well as resources to pass on to patients. Published by Springer, the book will be available in softcover and ebook on May 31. Preorder here.
Correlates of Pregnancy Before Age 15 Compared With Pregnancy Between the Ages of 15 and 19 in the United States
A Section study examining the effects of very early teen pregnancy was published in Obstetrics & Gynecology online and also picked up by Reuters. Dr. Marcela Smid, a former OB-GYN resident at The University of Chicago Medical Center, coathored the paper with Section chief Dr. Melissa Gilliam, Section faculty Dr. Amy Whitaker, and then-Section staff Summer Martins, MPH.
Postplacental insertion of the levonorgestrel intrauterine device after cesarean delivery vs. delayed insertion: a randomized controlled trial
Dr. Amy Whitaker and Section chief Dr. Melissa Gilliam co-authored an article e-published in Contraception that discusses their randomized controlled trial (RCT) designed to compare levonorgestrel intrauterine device (LNG-IUD) use at one year after delivery between women who received the device at the time of cesarean delivery and those who underwent delayed insertion 4-8 weeks after delivery.